Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells

Blood

Volumn 101, Issue 6, 2003, Pages 2191-2198

  Laufs, Stephanie ^b   Gentner, Bernhard ^b   Nagy, K Zsuzsanna ^b   Jauch, Anna ^b   Benner, Axel ^b   Naundorf, Sonja ^b   Kuehlcke, Klaus ^b   Schiedlmeier, Bernhard ^b   Ho, Anthony D ^b   Zeller, W Jens ^b   Fruehauf, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW; CELL TRANSPLANTATION; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 6; GENE TARGETING; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MUTAGENESIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; STEM CELL;

EID: 0037443442     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0627     Document Type: Article

References (60)

1. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science. 2000;287:1442-1446.
2. Almeida-Porada G, Porada C, Zanjani ED. Adult stem cell plasticity and methods of detection. Rev Clin Exp Hematol. 2001;5:26-41.
3. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5: 309-313.
4. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
5. + cells from HIV-exposed infants: preclinical studies. Gene Ther. 1998;5:233-239.
6. Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med. 2000;6:1235-1240.
7. Tran ND, Porada CD, Almeida-Porada G, Glimp HA, Anderson WF, Zanjani ED. Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood. 2001;97:3417-3423.
8. Fruehauf S, Haas R, Conradt C, et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood. 1995;85:2619-2626.
9. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233-2258.
10. Abonour R, Williams DA, Einhorn L, et al. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med. 2000;6:652-658.
11. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288:669-672.
12. Li Z, Dullmann J, Schiedlmeier B, et al. Murine leukemia induced by retroviral gene marking. Science. 2002;296:497.
13. Bonetta L. Leukemia case triggers tighter gene-therapy controls. Nat Med. 2002;8:1189.
14. Dick JE, Magli MC, Huszar D, Phillips RA, Bernstein A. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell. 1985;42:71-79.
15. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 1990;4:220-232.
16. Barquinero J, Segovia JC, Ramirez M, et al. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice. Blood. 2000;95:3085-3093.
17. Guenechea G, Gan OI, Dorrell C, Dick JE. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immun. 2001;2:75-82.
18. Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci. U S A. 1996;93:2414-2419.
19. Kim HJ, Tisdale JF, Wu T, et al. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood. 2000;96:1-8.
20. Gentner B, Laufs S, Nagy KZ, Zeller WJ, Fruehauf S. Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with partly arbitrary primers. Gene Ther. In press.
21. Rosenthal A, Jones DS. Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction. Nucleic Acids Res. 1990;18: 3095-3096.
22. Schmidt M, Hofmann G, Hesemann CU, Mertelsmann R, von Kalle C. Extension primer tag selection followed by solid-phase ligation-mediated (LM) PCR represents a powerful tool for the clonality analysis of transduced hematopoietic cell clones [abstract]. Ann Hematol. 1998;77:53.
23. Schmidt M, Hoffmann G, Wissler M, et al. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther. 2001;12:743-749.
24. Schilz AJ, Schiedlmeier B, Kuhlcke K, et al. MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. Mol Ther. 2000;2:609-618.
25. Eckert HG, Kuhlcke K, Schilz AJ, et al. Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 I gene (MDR1). Bone Marrow Transplant. 2000;25: 114-117.
26. Eckert HG, Stockschlader M, Just U, et al. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood. 1996;88:3407-3415.
27. Schiedlmeier B, Kuhlcke K, Eckert HG, Baum C, Zeller WJ, Fruehauf S. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood. 2000;95:1237-1248.
28. Fruehauf S, Breems DA, Knaan-Shanzer S, et al. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum Gene Ther. 1996;7:1219-1231.
29. Lichter P, Cremer T. Chromosome analysis by non-isotopic in situ hybridization. In: Rooney DE, Czepulkowski BH, eds. Human Genetics - A Practical Approach. 2nd ed. Oxford, United Kingdom: IRL Press; 157-192.
30. Speicher MR, Gwyn Ballard S, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet. 1996;12:368-375.
31. Müler S, Neusser M, Wienberg J. Towards unlimited colors for fluorescence in situ hybridization (FISH). Chromosome Res. 2002;10:223-232.
32. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics. 1992;13:718-725.
33. Schiedlmeier B, Schilz AJ, Kühlcke K, et al. Multidrug resistance-1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice. Hum Gene Ther. 2002;13:233-242.
34. Sorrentino BP, McDonagh KT, Woods D, Orlic D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice, Blood. 1995;86: 491-501.
35. Knipper R, Kuehlcke K, Schiedlmeier B, et al. Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells. Gene Ther. 2001;8:239-246.
36. Kurdi-Haidar B, Friedmann T. Simplified plasmid rescue of host sequences adjacent to integrated proviruses. Gene. 1996;168:199-203.
37. Schmidt M, Zickler P, Hoffmann G, et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood. 2002;100:2737-2743.
38. Cavrois M, Wain-Hobson S, Wattel E. Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol, 1995; 146:179-184.
39. Dao MA, Yu XJ, Nolta JA. Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in mmune-deficient mice. Exp Hematol. 1997;25:1357-1366.
40. Nash R, Storb R, Neiman P. Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood, 1988;72:2031-2037.
41. Turhan AG, Humphries RK, Phillips GL, Eaves AC, Eaves CJ. Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation. N Engl J Med. 1989;320:1655-1661.
42. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329-1337.
43. Greiner DL, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells. 1998;16:166-177.
44. Cashman JD, Lapidot T, Wang JC, et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 1997;89:4307-4316.
45. , Gothot A, van der Loo JC, Clapp DW, Srour EF. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 1998;92:2641-2649.
46. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404: 193-197.
47. Dick JE, Guenechea G, Gan OI, Dorrell C. In vivo dynamics of human stem cell repopulation in NOD/SCID mice. Ann N Y Acad Sci. 2001;938: 184-190.
48. Leclercq I, Mortreux F, Cavrois M, et al. Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J Virol. 2000;74:2305-2312.
49. Holmes-Son ML, Appa RS, Chow SA. Molecular genetics and target site specificity of retroviral integration. Adv Genet. 2001;43:33-69.
50. Shibagaki Y, Chow SA. Central core domain of retroviral integrase is responsible for target site selection. J Biol Chem. 1997;272:8361-8369.
51. Weidhaas JB, Angelichio EL, Fenner S, Coffin JM. Relationship between retroviral DNA integration and gene expression. J Virol. 2000;74:8382-8389.
52. Vijaya S, Steffen DL, Robinson HL. Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. J Virol. 1986; 60:683-692.
53. Kitamura Y, Lee YM, Coffin JM. Nonrandom integration of retroviral DNA in vitro: effect of CpG methylation. Proc Natl Acad Sci U S A. 1992;89: 5532-5536.
54. Leclercq I, Mortreux F, Cavrois M, et al. Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J Virol. 2000;74:2305-2312.
55. Mielke C, Maass K, Tummler M, Bode J. Anatomy of highly expressing chromosomal sites targeted by retroviral vectors. Biochemistry. 1996;35:2239-2252.
56. Pruss D, Bushman FD, Wolffe AP. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci U S A. 1994;91: 5913-5917.
57. Katz RA, Gravuer K, Skalka AM. A preferred target DNA structure for retroviral integrase in vitro. J Biol Chem. 1998;273:24190-24195.
58. Withers-Ward ES, Kitamura Y, Barnes JP, Coffin JM. Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev. 1994;8: 1473-1487.
59. Schmidt T, Zornig M, Beneke R, Moroy T. Mo-MuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene. Nucleic Acids Res. 1996;24:2528-2534.
60. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521-529.